ArticleJTCVS open2026

Transitioning from neoadjuvant chemoradiation to perioperative chemotherapy for esophageal adenocarcinoma: Impact on margins and pathologic outcomes.

Paolo de Angelis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.